Changing your EMS company looks like just a pricing decision, but it's much more than that. It is a transfer of risk, working capital, and institutional knowledge, and in reality, the price list is the smallest part of it.
Most OEMs start in the same place: a quotation from a new supplier that comes in lower than the incumbent's. That gap is real, but it only tells you what steady state might look like in a year or two. It says nothing about what it costs to get there. This guide sets out the cost lines to model, the ones OEMs most often underestimate, and a decision matrix to help you work out whether switching is genuinely the right call.
There is no single figure, but the structure of the answer is consistent. The total cost of changing your EMS company is the unit price difference, plus the one-off transition costs, plus the working capital tied up while both suppliers are live.
A typical transfer runs three to six months of parallel production, longer for regulated products or high-mix box build. During that window you are paying for two supply chains, two sets of test resources, and a significant amount of your own team's time. Payback on a lower unit price often lands somewhere between 12 and 24 months once those costs are counted honestly, and it can be longer where tooling and requalification are heavy. The point is not to be discouraged by that number, but to know it before you sign, so the business case survives contact with reality.
Of the things that have dramatically shifted over the last few years, here are three that most affect the budget number:
| Cost line | What drives it | How to estimate it |
| Unit price difference | Material cost, labour rate, and the level of automation applied to your build | Ask both suppliers to split material and labour. Compare like for like at your actual annual volumes, not at a headline break quantity |
| Non-recurring engineering and tooling | New fixtures, jigs, programming, stencils, and injection mould tools | Get it itemised. Treat any offer of free NRE with caution, because the cost is usually recovered through unit price |
| Test development and transfer | Rewriting or revalidating test programmes, and correlating results across two sites | Scope it with your test engineer, not with procurement alone |
| Dual inventory | Finished goods, work in progress, and components held at both suppliers during parallel running | Model months of cover multiplied by your cost of capital, and add any obsolescence risk |
| Last-time buys and buffer stock | Components the incumbent holds under a buffer agreement, plus long lead time for parts the new partner cannot secure quickly | Review the bill of materials for single-source and long lead time items first |
| Requalification and approvals | Process validation, first article inspection, customer or notified body notification | Budget calendar time as well as cost. This often sets the critical path |
| Internal team time | Engineering, quality, procurement, and programme management hours across the transfer | Estimate days per function per month, then price them at loaded cost |
| Ramp-up yield and rework | The learning curve on a new line, plus any scrap and rework during qualification builds | Assume the first builds will not hit steady state yield. Agree who carries that cost, in writing |
For three to six months you are funding two supply chains. Components arrive at the new partner while finished goods still ship from the old one, and the incumbent may hold buffer stock you are contractually obliged to take. Where a temporary demand spike outruns that buffer, procurement teams can end up sourcing through brokers at a premium, which is both expensive and a counterfeit risk. Read the exit terms in your existing agreement before you model anything else.
In regulated sectors this is not a formality. Medical device manufacturers operating in the United States have been subject to the FDA's Quality Management System Regulation since 2 February 2026, which aligns quality system expectations with ISO 13485:2016 and puts supplier control and process validation firmly in scope.
In the European Union, Regulation (EU) 2017/745 places equivalent responsibility on the manufacturer regardless of who builds the product. Automotive programmes following IATF 16949:2016 generally require customer notification and fresh production part approval when manufacturing moves to a new location. None of that is impossible, but all of it takes time.
This is usually the largest hidden cost, and the hardest to recover. A transfer pulls senior engineering, quality, and procurement people away from new product work for months. If your next product launch slips by a quarter because your best engineers were validating a transferred line, the opportunity cost may dwarf the unit price saving that triggered the move.
Not every performance problem needs a new supplier. Use the matrix below to separate the issues that can be fixed inside the current relationship from the ones that genuinely justify a transfer.
| Signal | Likely fixable with the incumbent | A genuine reason to switch |
| Quality | Isolated defects with credible root cause analysis and corrective action that holds | Repeat escapes, weak corrective action, or a certification scope that does not cover your product class |
| On-time delivery | Slippage tied to a known component shortage affecting the whole market | Chronic misses while competitors on the same parts are shipping |
| Cost | Price rises you can trace to material indices, currency, or labour inflation | No visibility into the material and labour split, or reluctance to be transparent |
| Capacity | Short-term constraint with a credible investment plan behind it | No headroom for your growth forecast, or your programme is too small to command attention |
| Footprint | Logistics cost you can offset with better planning or consolidated shipments | Tariff exposure, customer pressure to nearshore, or a single-region dependency your board will not accept |
| Engineering support | Slow response that improves with a clearer escalation path | No design for excellence input, no NPI capability, and no appetite to build it |
| Culture and transparency | Communication gaps that a quarterly business review can close | Surprises you find out about from your own customers |
If most of your issues fall in the left column, the cheaper move is to fix the relationship. If they fall in the right column, the cost of staying is compounding without you realising it, and the transfer cost is the price of stopping it.
Run the transfer as a project, with a named owner and a plan, rather than as a procurement action with an engineering afterthought. Phase it by product family so you are never carrying dual inventory across your whole portfolio at once. Agree the buffer stock unwind with your incumbent in writing before you serve notice. Ask the incoming partner to price the transfer itself, not just the steady state build, and to show you the transfer plans they have executed before. Finally, ask who carries the cost of qualification builds and ramp-up yield, and get the answer in the contract.
The cost of changing your EMS company is knowable. It is the unit price difference, the transition costs, and the working capital you tie up getting from one supplier to the other. Model all three, then compare that number against the cost of another two years of the performance you have now. A good transfer pays for itself. A transfer built on a unit price comparison alone rarely does.
The best way to test the number is to put it in front of a partner who has run transfers before and will talk you through where the time and money actually go. ESCATEC is an EMS partner that supports OEMs across the full product lifecycle, and our global sites let OEMs build nearshore, co-shore, or offshore within a single quality system, which keeps transfers simpler as your programme grows.
If you are weighing up a change, get more expert insights from our free outsourcing guide, or talk to our team about your transfer and we can help you model it properly.
Editor's note: This blog was first published in 2014,but has revised and republished for relevance and accuracy in October 2026.
Most transfers run three to six months of parallel production, and longer for regulated products or complex box build assemblies. Requalification and test transfer usually set the critical path, not the physical move of tooling or stock.
Internal team time is usually the largest cost that never appears in a quotation. Engineering, quality, and procurement people are pulled onto the transfer for months, which delays other work. Dual inventory across two suppliers is the second largest.
Rarely on its own. A lower unit price has to recover the transition costs and the working capital tied up during parallel running before it delivers a saving. Payback frequently falls between 12 and 24 months, and longer where tooling or requalification is significant.
In most regulated sectors, yes. Medical device manufacturers have been subject to the FDA's Quality Management System Regulation since 2 February 2026, and EU Regulation 2017/745 places responsibility for supplier control on the manufacturer. Automotive programmes under IATF 16949:2016 generally require customer notification and renewed production part approval when manufacturing moves site.
Stay when the problems are traceable, time-limited, and being actively corrected, for example delivery slippage caused by a market-wide component shortage. Switch when the issues are structural: no capacity headroom for your growth, no visibility into cost, a footprint that no longer suits your markets, or repeat quality escapes without effective corrective action.